Allison Shuren's guest appearances

Allison Shuren

Critical Issues in Eyecare: An MD/OD Conversation

Mitch Jackson

John Novak

Eric Donnenfeld

John Scibal

Kerry Solomon

Marc Bloomenstein

Paul Karpecki

Richard Lindstrom

Kirk Smick

Thomas Pusateri

Marguerite McDonald

Myra Cherchio

George Waring

Guy Kezirian

Jeff Walline

OwlTail

Join us for this important discussion on payment models in the eyecare industry. Lawyer Allison Shuren joins regular hosts Mitchel Jackson, MD and Nate Bonilla-Warford, OD to talk about about the change payment landscape. New payment models for eyecare are discussed, such as pay-for-performance, bundled disease state management, capitated risk arrangements, and collaborative care.     Topics include: Is pay-for-performance a new trend? Or an old one "on steroids"?  How can doctors push back against these changes?   Can these changes be expected to impact the relationship between optometrists and ophthalmologists?   Do these payment systems essentially mandate EMR in the practice?   And, the million dollar question, what affect will the US election have on the new payment systems?    About Allison Shuren:   Allison Shuren co-chairs the Life Sciences and Healthcare Regulation Practice and advises a wide range of health care clients on regulatory, compliance, enforcement, and legislative matters. Her clients include large international manufacturers of medical devices, pharmaceuticals, biologics, emerging companies with early stage concepts, hospitals and integrated health networks, ambulatory surgery centers, diagnostic testing facilities, clinical laboratories, dialysis centers physicians, physician practice management companies, and developers of mobile and digital health technology. A primary focus of Ms. Shuren’s practice is compliance with health regulatory requirements, especially the healthcare fraud and abuse laws. She counsels on complex referral arrangements as well as sales and marketing programs, including discounts and rebates, represents clients in government investigations and qui tam actions involving False Claims Act, Anti-Kickback Statute, Stark Law, and health care fraud allegations. She regularly interacts with the US Department of Health and Human Services Office of Inspector General, the US Department of Justice, and the Centers for Medicare and Medicaid Services. She also leads internal compliance investigations and regulatory due diligence related acquisitions and investments. Ms. Shuren’s goal is to be a trusted advisor who helps clients meet legal requirements while achieving success in a competitive healthcare marketplace.

Join us for this important discussion on payment models in the eyecare industry. Lawyer Allison Shuren joins regular hosts Mitchel Jackson, MD and Nate Bonilla-Warford, OD to talk about about the change payment landscape. New payment models for eyecare are discussed, such as pay-for-performance, bundled disease state management, capitated risk arrangements, and collaborative care.     Topics include: Is pay-for-performance a new trend? Or an old one "on steroids"?  How can doctors push back against these changes?   Can these changes be expected to impact the relationship between optometrists and ophthalmologists?   Do these payment systems essentially mandate EMR in the practice?   And, the million dollar question, what affect will the US election have on the new payment systems?    About <a href="http://www.arnoldporter.com/en/people/s/shuren-allison-w" rel="nofollow" target="_blank">Allison Shuren</a>:   Allison Shuren co-chairs the Life Sciences and Healthcare Regulation Practice and advises a wide range of health care clients on regulatory, compliance, enforcement, and legislative matters. Her clients include large international manufacturers of medical devices, pharmaceuticals, biologics, emerging companies with early stage concepts, hospitals and integrated health networks, ambulatory surgery centers, diagnostic testing facilities, clinical laboratories, dialysis centers physicians, physician practice management companies, and developers of mobile and digital health technology. A primary focus of Ms. Shuren’s practice is compliance with health regulatory requirements, especially the healthcare fraud and abuse laws. She counsels on complex referral arrangements as well as sales and marketing programs, including discounts and rebates, represents clients in government investigations and qui tam actions involving False Claims Act, Anti-Kickback Statute, Stark Law, and health care fraud allegations. She regularly interacts with the US Department of Health and Human Services Office of Inspector General, the US Department of Justice, and the Centers for Medicare and Medicaid Services. She also leads internal compliance investigations and regulatory due diligence related acquisitions and investments. Ms. Shuren’s goal is to be a trusted advisor who helps clients meet legal requirements while achieving success in a competitive healthcare marketplace.

22: Payment Models in the Eyecare Industry with Allison Shuren